Gastroenterology

Gastroenterology

Volume 114, Issue 2, February 1998, Pages 336-343
Gastroenterology

Liver, Pancreas, and Biliary Tract
Increased adrenomedullin levels in cirrhosis: Relationship with hemodynamic abnormalities and vasoconstrictor systems,☆☆

https://doi.org/10.1016/S0016-5085(98)70486-XGet rights and content

Abstract

Background & Aims: Arterial vasodilation in cirrhosis may be related to increased circulating levels of vasodilators. This study was designed to assess the circulating levels of adrenomedullin, a recently described vasodilator peptide, in cirrhosis. Methods: Plasma adrenomedullin levels were measured in 17 healthy subjects and 34 cirrhotic patients. Hemodynamic parameters, renal function, and levels of vasoactive substances were also assessed. Results: Patients with ascites had increased adrenomedullin levels (289 ± 47 pg/mL) compared with healthy subjects and patients without ascites (135 ± 17 and 142 ± 32 pg/mL, respectively; P < 0.05). Adrenomedullin levels correlated inversely with arterial pressure, glomerular filtration rate, and renal plasma flow and correlated directly with pulse rate, endothelin levels, and aldosterone and plasma renin activity. In cirrhotic patients, no significant differences in adrenomedullin levels were found between samples obtained from hepatic vein, renal vein, pulmonary artery, and femoral artery. Plasma expansion with albumin suppressed the renin-angiotensin system but did not affect adrenomedullin levels. Conclusions: Circulating levels of adrenomedullin are increased in patients with ascites and correlate with hemodynamic and renal abnormalities and activation of vasoconstrictor systems. These increased levels seem to result from a generalized increase in adrenomedullin production from vascular tissue and are not suppressed by plasma expansion. Adrenomedullin may participate in the pathogenesis of arterial vasodilation in cirrhosis.

GASTROENTEROLOGY 1998;114:336-343

Section snippets

Patients and methods

The present study included three protocols approved by the Investigation and Ethics Committee of the Hospital Clínic i Provincial of Barcelona. Informed consent was obtained from each subject studied. All subjects included were studied after 6 days on a 40-mEq/day sodium diet. In cirrhotic patients, diuretics were withdrawn during the same period.

Circulating levels of AM in patients with cirrhosis: Relationship with systemic hemodynamics, renal function, and vasoactive factors

Table 1 shows the demographic data and liver and renal function test results in the three groups of subjects.

. Demographic data and liver and renal function tests in the three groups of subjects

Empty CellHealthy subjects (n = 17)Cirrhotics without ascites (n = 9)Cirrhotics with ascites (n = 25)P value (ANOVA)
Sex (M/F)11/68/116/9NS
Age (yr)51 ± 659 ± 558 ± 2NS
Etiology of cirrhosis (viral/alcohol)5/412/13NS
Serum bilirubin (mg/dL)0.7 ± 0.11.6 ± 0.2a**6.8 ± 2a**,b**<0.001
Serum albumin (g/L)47 ± 134 ± 2a***27

Discussion

Under physiological conditions, AM is mainly synthetized in vascular tissue, adrenal medulla, heart, lungs, and kidneys.25, 26, 27, 28, 29 The greatest expression of AM messenger RNA has been found in endothelial cells.30 Moreover, endothelial cells in culture secrete AM constitutively in a manner similar to the vasoconstrictor peptide endothelin.30 The main biological effect of AM is vascular relaxation. Administration of AM to experimental animals is associated with arterial hypotension,

Acknowledgements

The authors thank Raquel Cela, R.N., Carme Escofet, R.N., and Núria Pons, R.N., for expert technical assistance and the nursing staff of the Liver Unit for their help.

References (46)

  • Y Ichiki et al.

    Distribution and characterization of immunoreactive rat adrenomedullin in human tissue and plasma

    FEBS Lett

    (1994)
  • J Sakata et al.

    Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma

    FEBS Lett

    (1994)
  • K Kuwasako et al.

    Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla

    Biochem Biophys Res Commun

    (1995)
  • S Sugo et al.

    Endothelial cells actively synthesize and secrete adrenomedullin

    Biochem Biophys Res Commun

    (1994)
  • Y Ishiyama et al.

    Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats

    Eur J Pharmacol

    (1993)
  • H He et al.

    Effect of a synthetic rat adrenomedullin on regional hemodynamics in rats

    Eur J Pharmacol

    (1995)
  • K Kitamura et al.

    Immunoreactive adrenomedullin in human plasma

    FEBS Lett

    (1994)
  • K Sato et al.

    Characterization of immunoreactive adrenomedullin in human plasma and urine

    Life Sci

    (1995)
  • Y Ishizaka et al.

    Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells

    Biochem Biophys Res Commun

    (1994)
  • S Eguchi et al.

    Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells

    FEBS Lett

    (1994)
  • S Moller et al.

    Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic hemodynamics

    J Hepatol

    (1995)
  • A Leivas et al.

    Endothelin-1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites

    Gastroenterology

    (1995)
  • D Rockey

    The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide

    Hepatology

    (1997)
  • Cited by (0)

    Supported by grant FIS/97/2073 from the Fondo de Investigaciones Sanitarias and Dirección General de Investigación Científica y Técnica (SAF96-0131 and SAF96-0082); a grant from the Fundació Clínic per la Recerca Biomèdica (to M.G.); grant 96/1723 from the Fondo de Investigación Sanitaria (to G.F-E.); a fellowship grant from the Hospital Clínic i Provincial of Barcelona (to P.S.); and a fellowship grant from the Comisió Interdeparta mental de Recerca i Innovació Tecnològica (to R.B.).

    ☆☆

    Address requests for reprints to: Pere Ginès, M.D., Liver Unit, Hospital Clínic i Provincial, Villarroel 170, 08036 Barcelona, Spain. Fax: (34) 3-451-52-72.

    View full text